AU6219594A - Calcium antagonist - Google Patents

Calcium antagonist

Info

Publication number
AU6219594A
AU6219594A AU62195/94A AU6219594A AU6219594A AU 6219594 A AU6219594 A AU 6219594A AU 62195/94 A AU62195/94 A AU 62195/94A AU 6219594 A AU6219594 A AU 6219594A AU 6219594 A AU6219594 A AU 6219594A
Authority
AU
Australia
Prior art keywords
calcium antagonist
antagonist
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62195/94A
Inventor
Chikako Ishikawa
Kiyosi Kondo
Yasunori Momose
Kazunaga Yazawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Original Assignee
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute filed Critical Sagami Chemical Research Institute
Publication of AU6219594A publication Critical patent/AU6219594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
AU62195/94A 1993-03-10 1994-03-09 Calcium antagonist Abandoned AU6219594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5-75034 1993-03-10
JP5075034A JPH06263634A (en) 1993-03-10 1993-03-10 Calcium antagonistic
PCT/JP1994/000373 WO1994020092A1 (en) 1993-03-10 1994-03-09 Calcium antagonist

Publications (1)

Publication Number Publication Date
AU6219594A true AU6219594A (en) 1994-09-26

Family

ID=13564513

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62195/94A Abandoned AU6219594A (en) 1993-03-10 1994-03-09 Calcium antagonist

Country Status (3)

Country Link
JP (1) JPH06263634A (en)
AU (1) AU6219594A (en)
WO (1) WO1994020092A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010129A1 (en) 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa ESSENTIAL FATTY ACIDS IN THE THERAPY OF HEART INSUFFICIENCY AND HEART FAILURE
ITMI20012384A1 (en) * 2001-11-12 2003-05-12 Quatex Nv USE OF POLYUNSATURATED FATTY ACIDS FOR THE PRIMARY PREVENTION OF MAJOR CARDIOVASCULAR EVENTS
JP4153330B2 (en) 2003-02-28 2008-09-24 サントリー株式会社 Process for producing powder compositions of ascorbic acid ester compounds of highly unsaturated fatty acids and their compositions

Also Published As

Publication number Publication date
WO1994020092A1 (en) 1994-09-15
JPH06263634A (en) 1994-09-20

Similar Documents

Publication Publication Date Title
AU7583794A (en) 1-amino-ethylindole-derivatives
AU6001594A (en) Imidazoazines
AU1273195A (en) Tachykinin antagonists
AU6710294A (en) Tetrahydro-beta-carbolines
AU1272295A (en) Proinsulin-like compounds
AU6705294A (en) Tetrahydro-pyrido-indole
AU6856796A (en) Des-arg9-bk antagonists
HU9400118D0 (en) Substituted dialkyl-thioethers
AU7220794A (en) Detergent-package combination
AU4931693A (en) Ibuprofen-h2 antagonist combinations
AU5261093A (en) Aminoalkylphenyl compounds
AU5798394A (en) Thiadiazinones
AU6259294A (en) Life-savingfloat
AU1274295A (en) Heteroarylpyrroles
AU6389494A (en) Tv-projector
AU6246894A (en) Gnrh antagonists
AU8104694A (en) Bagbottle
AU6219594A (en) Calcium antagonist
AU6971594A (en) Cyclobutylazoles
AU6161894A (en) Cholecystokinin antagonists
AU6427194A (en) Aza-androstane-17beta -carboxamides
AU5780894A (en) Crankhead
AU3696093A (en) Aquamate
AU7285994A (en) Suncap
AU4833093A (en) Construction set